HYDERABAD– Telangana Chief Minister A. Revanth Reddy said Tuesday that Hyderabad has the potential to evolve from being a global vaccine hub into a leading global life sciences capital, citing the city’s growing ecosystem, policy support, and talent base.
Speaking at the inauguration of BioAsia 2026 alongside IT and Industries Minister D. Sridhar Babu, Reddy said the annual event reflects Hyderabad’s success as a life sciences center and expressed confidence that BioAsia could eventually gain global stature comparable to major international economic and industry forums.
The chief minister outlined several strengths underpinning Telangana’s ambitions, including a clear policy vision, availability of highly skilled human resources, and strong educational institutions. He noted that Hyderabad has also emerged as a major hub for Global Capability Centers, with capabilities spanning research, design, and innovation.
Reddy highlighted recent initiatives such as the launch of the Telangana Next-Generation Life Sciences Policy, the expansion of Genome Valley, the rollout of world-class research and innovation facilities, the acceleration of Green Pharma City, and the establishment of multiple global capability centers in Hyderabad.
“In the last two years, we have received over Rs 73,000 crore in life sciences investments,” he said.
According to the chief minister, Hyderabad has become a preferred destination for companies looking to build innovation engines, design molecules and drugs, manage clinical analytics, develop AI platforms, and drive digital manufacturing.
Citing strong international participation at BioAsia, Reddy said the event’s global reach could eventually warrant a broader identity, reflecting its growing international relevance. He added that Hyderabad now hosts major thought leaders and business executives across pharmaceuticals, biotechnology, bulk drugs, vaccines, and healthcare.
Reddy said the city has developed into a trusted and future-ready ecosystem, adding that Telangana is steadily moving up the value chain, from manufacturing to innovation and from domestic to global markets.
Addressing the gathering, Minister Sridhar Babu said the state is targeting $25 billion in life sciences investments and the creation of 500,000 jobs by 2030. He said Telangana aims to position itself among the world’s top three life sciences clusters through a clear and structured roadmap.
He added that the state is shifting from supply-led manufacturing toward solution-driven global leadership by building a ready-to-work talent pool in areas such as mRNA technologies, gene editing, and AI-led drug discovery, while strengthening Hyderabad’s role in next-generation innovation and medical tourism.
BioAsia 2026 attracted more than 4,000 delegates representing about 500 leading companies from the global life sciences ecosystem.
During the event, the chief minister presented the Genome Valley Excellence Award to Prof. Bruce Levine of the University of Pennsylvania.
